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The purpose of this study was to observe the effects of autonomic nerve pharmacopunc-
ture (ANP) treatment on cancer-related fatigue (CRF) in patients with advanced cancer.
This observational case study was conducted at the East West Cancer Center of Daejeon
University’s Dunsan Korean Medical Hospital. Two patients were observed. One patient
was diagnosed with left thymic cancer metastatic to the left pleura. The other patient
had terminal-stage cervical cancer with iliac bone and lumbar 5 metastases. We injected
mountain ginseng pharmacopuncture (MGP) into acupoints alongside the spine (Hua-Tuo-
Jia-Ji-Xue, EX B2). We examined the patients for CRF using the Korean version of the
Revised Piper Fatigue Scale (RPFS-K), which is a self-assessment tool. The scores on
the RPFS-K for both patients tended to decrease during the treatment. Laboratory find-
ings, including hematological changes, were also checked. Liver and renal function tests
showed that the treatment was safe. Although further large-population studies are neces-
sary, this case study suggests that ANP has a favorable effect on CRF in patients with
advanced cancer.ancer Center, Dunsan Korean Medical Hospital of Daejeon University, 176-75 Daedukdaero, Seo-gu,
5.04.003
acopuncture Institute.
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Fatigue in patients with advanced cancer is a commonly
seen symptom. Cancer-related fatigue (CRF) has been
defined by the United States National Comprehensive
Cancer Network as “A distressing, persistent, subjective
sense of tiredness or exhaustion related to cancer or cancer
treatment and is disproportionate to the level of recent
activity, is not relieved by rest and interferes with usual
daily activities” [1]. Fatigue and anorexia are the top two
symptoms that bother patients with cancer, and these
symptoms have a significant impact on the quality of life,
leading to a poor prognosis, even in the course of after-
treatment [2].
Liu et al [3] reported the result of a retrospective
cohort study of the symptoms and the survival rate of 256
advanced cancer patients experiencing fatigue, and CRF
was identified as a factor closely related to survival [3].
CRF often occurs during the course of radiation therapy or
chemotherapy, or is caused by the cancer itself, as well
as malnutrition, pain, decreased physical activity,
emotional distress, insomnia, and hypothyroidism [4].
When the cause of the fatigue is apparent, medication is
attempted. For example, if anemia, insomnia, and/or
depression are identified as the causes of fatigue, anti-
depressants, corticosteroids, and mental stimulant ther-
apy can be used [5], however, such Western medicines
may induce side effects [6]. Recently, Zeng et al [7]
published a meta-analysis of randomized controlled tri-
als of acupuncture for the treatment of CRF, and Su et al
[8] published a systematic review of randomized clinical
trials of Chinese herbal medicine for the treatment of
CRF. Nevertheless, few clinical reports of the use of
pharmacopuncture for treating cancer-related CRF have
been published.
Autonomic nerve pharmacopuncture (ANP) is a therapy
based on subcutaneous injection of mountain ginseng
pharmacopuncture (MGP) into the acupoints alongside the
spine (Hua-Tuo-Jia-Ji-Xue, EX B2) [9]. EX B2 is located at
the branches of the autonomic nervous system [10]. The
rationale for this approach is that subcutaneous MGP in-
jection directly into the EX B2 acupoint is expected to
enhance the balance in the autonomic nerve function,
resulting in a positive effect on CRF. Here, we report a
reduction in CRF for patients with advanced cancer after
ANP.2. Case Presentation2.1. Materials
One milliliter from a 20-mL solution of MGP was injected
into 10 EX B2 acupuncture points. Each 20-mL pharmaco-
puncture vial contained 3 g of mountain ginseng (15%). The
process for preparing the MGP consisted of washing an
entire mountain ginseng plant, extracting the active
ingredient by distillation for 4 hours (pH 7.35e7.45) in a
clean room, filtering it twice, and sealing in 20-mL aliquots
in sterilized glass containers [9].2.2. Methods
In Case 1, ANP was injected into the sites corresponding to
the T1, T2, T3, T4, T5, T6, T7, T8, T9, and T10 0.5 cun
lateral on the both sides of the intervertebral joint. In Case
2, ANP was injected into the sites corresponding to the L1,
L2, L3, L4, L5, S1, S2, S3, S4, and S5 0.5 cun lateral to both
sides of each intervertebral joint. The acupuncture points
were chosen from the transport points associated with the
organs affected by the cancer.
The Revised Piper Fatigue Scale (RPFS), a tool for
assessing CRF in cancer patients, was developed in the
United States [11]. Lee [12] modified this form and
developed a Korean version of the RPFS (RPFS-K) with a
total of 19 questions in the active area, emotional area,
sensory area, and cognitive/mood area. All patients
completed the RPFS-K questionnaire before treatment,
each day after treatment, and at the end of treatment.
Cronbach’s alpha was used to estimate the reliability of
this assessment tool. It yields a value between 0 and 1,
with scores closer to 1 indicating a higher reliability. For
the RPFS-K, the reliability score was 0.93, which confirmed
its reliability and validity [13].
2.3. Case 1
Case 1 involved a 40-year-old female patient. The patient
was admitted from March 30, 2014 to April 12, 2014. In
February 2009, the patient had been diagnosed with thymic
cancer with metastasis to the left (Lt.) pleura. Common
complaints were fatigue, fever, anorexia, and itching (face,
anterior neck). Laboratory findings showed that after four
ANP treatments, the white blood cells had increased to
7190  103/mm3 on April 7, 2014, compared to 5410  103/
mm3 before treatment on March 31, 2014. The hemoglobin
level had remained unchanged, whereas the erythrocyte
sedimentation rate had decreased from 53 mm/h to
33 mm/h. The patient had been experiencing both itching
and swelling of the thyroid gland site on admission. A lab-
oratory test at admission showed a thyroglobulin antigen
(Ag) level of 1000 ng/mL, indicating inflammation of the
thyroid. After the ANP treatment, the thyroglobulin Ag
level had decreased to 0.3 ng/mL (see Table 1).
On admission, we obtained the patient’s signature on
the consent form and then injected ANP a total of four
times at 2-day or 3-day intervals. On April 4, 2014, we did
not inject ANP because of fever and itching, which were
assumed to be due to an inflammatory response. The self-
assessment total score was 166 at the time of admission and
had decreased to 46 by the end of the treatment (see
Figure 1).
2.4. Case 2
Case 2 involved a 61-year-old female patient. The patient
was admitted from April 11, 2014 to May 12, 2014. The
patient had been diagnosed with cervical cancer in
November 2012. On February 11, 2014, positron emission
tomography imaging showed tumor recurrence in the Lt.
ilium and pelvic wall, as well as metastases to the iliac bone
and L5 vertebra. Common complaints were fatigue, Lt.
Table 1 Laboratory findings (Case 1).
Laboratory
findings
Unit Normal
range
2014-03-31
(Before)
2014-04-07
(After)
WBC 103/mm3 4.5e11 5.41 7.19
Hemoglobin g/dL 12e16 11.2; 11.2;
ESR mm/h 0e20 53 : 33 :
Free T4 ng/dL 0.89e1.76 1.90 : 1.48
TSH mIU/mL 0.35e5.5 0.4 0.21;
Thyroglobulin
Ab
U/mL 0e115 28.3 472.9 :
Thyroglobulin
Ag
ng/mL 1.4e78 >1000.0 : 0.3;
: indicates a higher than normal value and; indicates a lower
than normal value.
Ab Z antibody; Ag Z antigen; ESR Z erythrocyte sedimenta-
tion rate; TSH Z thyroid stimulating hormone; WBC Z white
blood cell.
Table 2 Laboratory findings (Case 2).
Laboratory
findings
Unit Normal
range
2014-04-12
(Before)
2014-05-02
(After)
Total protein g/dL 6.6e8.6 6.4; 6.6
Albumin g/dL 3.5e5.2 3.4; 3.4;
AST U/L 0e31 27 20
ALT U/L 0e34 27 14
ALP U/L 30e120 111 96
r-GTP U/L 7e32 36 : 21
CRP mg/dL 0.5 8.70 : 5.79 :
WBC 103 mm3 4.5e11 5.41 6.22
Hemoglobin g/dL 12e16 11.7; 9.4;
ESR mm/h 0e20 54 : 65 :
: indicates a higher than normal value and; indicates a lower
than normal value.
ALP Z alkaline phosphatase, ALT Z alanine aminotransferase,
AST Z aspartate aminotransferase, CRP Z C-reactive protein;
ESR Z erythrocyte sedimentation rate, r-GTP Z g-glutamyl
transferase, WBC Z white blood cells.
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disturbance. Laboratory findings after the ANP treatment
showed that the total protein level had slightly increased to
6.6 g/dL compared to 6.4 g/dL before the treatment. Al-
bumin levels before and after ANP were similar. The level
of g-glutamyl transferase had decreased from 36 U/L to
21 U/L and that of C-reactive protein had decreased from
8.70 mg/dL to 5.79 mg/dL (see Table 2).
On admission, we obtained the patient’s signature on
the consent form and then conducted ANP (a total of 12
times) from April 14, 2014, to April 30, 2014. During the first
14 days of treatment, CRF decreased slightly. However, on
April 29, 2014, the patient’s lower limb pain began to
worsen, which seemed to be caused by the progress of her
spine metastatic lesion. The self-assessment total score
was 157 at the time of admission and had decreased to 125
by the end of the treatment (see Figure 2).3. Discussion
CRF is one of the most important factors affecting the
quality of life of cancer patients and is found in almost 90%Figure 1 Korean version of the Revised Piper Fatigue Scale (RPFS-
(Case 1). The scores of all factors were lower at the end of treatmof cancer patients [14]. Various mechanisms have been
proposed to underlie CRF, including 5-hydroxytryptamine
neurotransmitter dysregulation, vagal afferent activation,
alterations in muscle and adenosine triphosphate meta-
bolism, hypothalamicepituitaryeadrenal axis dysfunction,
circadian rhythm disruption, and cytokine dysregulation
[15]. Hyun et al [16] reported that acupuncture treatment
reduced fatigue associated with lung cancer. Jeong et al
[17] reported that bojungikki-tang helped to reduce CRF
and improve the quality of life of patients with cancer.
However, no clinical reports address the use of pharmaco-
puncture to treat cancer-related CRF.
ANP is a therapy that uses pharmacopuncture injection at
EX B2. Direct injection of MGP into the acupuncture points
anatomically analogous to the parts of the autonomic nerve
branches is thought to improve the balance and activation of
the autonomic function in the body. The autonomic nervous
system is activated by the hypothalamus, spinal cord, and
brain stem. This system regulates many activities of the
human body. In the autonomic nervous system, nerve fibersK) scores during autonomic nerve pharmacopuncture treatment
ent compared to those on admission.
Figure 2 Korean version of the Revised Piper Fatigue Scale (RPFS-K) scores during autonomic nerve pharmacopuncture treatment
(Case 2). The total score decreased slightly. However, on April 29, 2014, the total score was slightly increased due to severe cancer-
related pain. After the end of treatment, the measured total score was at its lowest.
Cancer-Related Fatigue in Patients 145originate from each ganglion on either side of the spine and
innervate each internal organ. Norepinephrine or acetylcho-
line is secreted through the ganglion, and these hormones act
on each organ, mediating the effects on the parasympathetic
and sympathetic nerves [18].
In this research, 20 mL of distilled MGP was used for the
ANP treatment.Mountain ginseng,whichbelongs to the family
Araliaceae, is awild perennial plant. It is also cultivated in the
mountainous areas of Korea by using young ginseng plants or
seeds [19]. The benefits of mountain ginseng that have been
identified to date include adjustments of nerve functions,
modulations of metabolic functions and fluids in the body, an
antidiuretic effect, increased sexual desire and performance,
increased resistance to stress, and enhanced digestion and
antibodyproduction [20]. Patientswith advancedcancerhave
difficulty taking herbal medicines orally. Thus, ANP can be
used in these patients to reduce CRF without the need for
medicines taken orally.
In the cases of our two patients, the scores associated
with CRF, measured using the RPFS-K, generally decreased.
During the treatment period, patients did not complain of
or present with any side effects of MGP. Our clinical data
indicate that the use of Korean medicine for the treatment
of CRF is effective. However, this study has a few limita-
tions, including a scale that was too small, heterogeneity
(two types of cancer), and a short treatment period. Large-
scale studies and randomized-controlled studies on ANP for
treating CRF in a cohort of patients with the same type of
cancer need to be performed.
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